CpG-Induced Stimulation of Cytokine Expression by Peripheral Blood Mononuclear Cells of Foals and Their Dams

Journal of Equine Veterinary Science

Volumn 28, Issue 7, 2008, Pages 419-426

  Liu, Tong ^a   Nerren, Jessica ^a   Murrell, Jennifer ^a   Juillard, Veronique ^b   El Garch, Hanane ^b   Martens, Ronald ^a   Cohen, Noah ^a  

^a TEXAS A AND M UNIVERSITY   (United States)

^b BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

Author keywords

Cytokines; Cytosine phosphate guanosine oligodeoxynucleotides (CpG ODNs); Foals; Gene expression; Immunomodulation; Peripheral blood mononuclear cells (PBMCs); Rhodococcus equi

Indexed keywords

BACTERIA (MICROORGANISMS); EQUIDAE; RHODOCOCCUS EQUI;

EID: 47049113422     PISSN: 07370806     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jevs.2008.05.005     Document Type: Article

References (62)

1. Van der Kolk H., Kraus H., and Vink-Nooteboom M. Rhodococcus equi pneumonia in a foal. Equine Pract 21 (1999) 6-9
2. Martens R.J., Martens J.G., and Fiske R.A. Rhodococcus equi foal pneumonia: pathogenesis and immunoprophylaxis. AAEP Proceedings (1989) 199-213
3. Darrah P.A., Monaco M.C., Jain S., Hondalus M.K., Golenbock D.T., and Mosser D.M. Innate immune responses to Rhodococcus equi J Immunol 173 (2004) 1914-1924
4. Giguere S., Hondalus M.K., Yager J.A., Darrah P., Mosser D.M., and Prescott J.F. Role of the 85-kilobase plasmid and plasmid-encoded virulence-associated protein A in intracellular survival and virulence of Rhodococcus equi. Infect Immun 67 (1999) 3548-3557
5. Patton K.M., McGuire T.C., Hines M.T., Mealey R.H., and Hines S.A. Rhodococcus equi-specific cytotoxic T lymphocytes in immune horses and development in asymptomatic foals. Infect Immun 73 (2005) 2083-2093
6. Prescott J.F., and Hoffman A.M. Rhodococcus equi. Vet Clin North Am: Equine Pract 9 (1993) 375-384
7. Drancourt M., Bonnet E., Gallais H., Pelloux Y., and Raoult D. Rhodococcus equi infection in patients with AIDS. J Infect 24 (1992) 123-131
8. Barouch D.H., Letvin N.L., and Seder R.A. The role of cytokine DNAs as vaccine adjuvants for optimizing cellular immune responses. Immunol Rev 202 (2004) 266-274
9. Kornbluth R.S., and Stone G.W. Immunostimulatory combinations: designing the next generation of vaccine adjuvants. J Leukoc Biol 80 (2006) 1084-1102
10. Kanaly S.T., Hines S.A., and Palmer G.H. Failure of pulmonary clearance of Rhodococcus equi infection in CD4+ T-lymphocyte-deficient transgenic mice. Infect Immun 61 (1993) 4929-4932
11. Ross T.L., Balson G.A., Miners J.S., Smith G.D., Shewen P.E., Prescott J.F., et al. Role of CD4+, CD8+ and double negative T-cells in the protection of SCID/beige mice against respiratory challenge with Rhodococcus equi. Can J Vet Res 60 (1996) 186-192
12. Giguere S., and Prescott J.F. Equine immunity to bacteria. Vet Clin North Am: Equine Pract 16 (2000) 29 iv
13. Nordmann P., Ronco E., and Nauciel C. Role of T-lymphocyte subsets in Rhodococcus equi infection. Infect Immun 60 (1992) 2748-2752
14. Meijer W.G., and Prescott J.F. Rhodococcus equi. Vet Res 35 (2004) 383-396
15. Patton K.M., McGuire T.C., Fraser D.G., and Hines S.A. Rhodococcus equi-infected macrophages are recognized and killed by CD8+ T lymphocytes in a major histocompatibility complex class I-unrestricted fashion. Infect Immun 72 (2004) 7073-7083
16. Chaffin M.K., Cohen N.D., Martens R.J., Edwards R.F., Nevill M., and Smith III R. Hematologic and immunophenotypic factors associated with development of Rhodococcus equi pneumonia of foals at equine breeding farms with endemic infection. Vet Immunol Immunopathol 100 (2004) 33-48
17. Martens R.J., Cohen N.D., Jones S.L., Moore T.A., and Edwards J.F. Protective role of neutrophils in mice experimentally infected with Rhodococcus equi. Infect Immun 73 (2005) 7040-7042
18. Lopez A.M., Hecker R., Mutwiri G., van Drunen Littel-van den Hurk S., Babiuk L.A., and Townsend H.G. Formulation with CpG ODN enhances antibody responses to an equine influenza virus vaccine. Vet Immunol Immunopathol 114 (2006) 103-110
19. Juffermans N.P., Leemans J.C., Florquin S., Verbon A., Kolk A.H., Speelman P., et al. CpG oligodeoxynucleotides enhance host defense during murine tuberculosis. Infect Immun 70 (2002) 147-152
20. Bauer M., Redecke V., Ellwart J., Scherer B., Kremer J.-P., Wagner H., et al. Bacterial CpG-DNA triggers activation and maturation of human CD11c-, CD123+ dendritic cells. J Immunol 166 (2001) 5000-5007
21. Krieg A.M. CpG motifs in bacterial DNA and their immune effects. Ann Rev Immunol 20 (2002) 709-760
22. Yamamoto S., Yamamoto T., Nojima Y., Umemori K., Phalen S., McMurry D.N., et al. Discovery of immunostimulatory CpG-DNA and its application to tuberculosis vaccine development. Jpn J Infect Dis 55 (2002) 37-44
23. Krieg A.M. The role of CpG motifs in innate immunity. Curr Opin Immunol 12 (2000) 35-43
24. Mutwiri G., Pontarollo R., Babiuk S., Griebel P., van Drunen Littel-van den Hurk S., Mena A., et al. Biological activity of immunostimulatory CpG DNA motifs in domestic animals. Vet Immunol Immunopathol 91 (2003) 89-103
25. Wilson H.L., Dar A., Napper S.K., Lopez A.M., Babiuk L.A., and Mutwiri G.K. Immune mechanisms and therapeutic potential of CpG oligodeoxynucleotides. Int Rev Immunol 25 (2006) 183-213
26. Krieg A.M. CpG motifs: the active ingredient in bacterial extracts?. Nat Med 9 (2003) 831-835
27. Tokunaga T., Yamamoto H., and Shimada S. Antitumor activity of deoxyribonucleic acid fraction from Mycobacterium bovis BCG.I. Isolation, physicochemical characterization, and antitumor activity. J Nat Cancer Inst 72 (1984) 955-962
28. Vollmer J., Janosch A., Laucht M., Ballas Z.K., Schetter C., and Krieg A.M. Highly immunostimulatory CpG-free oligodeoxynucleotides for activation of human leukocytes. Antisense Nucl Acid Drug Devel 12 (2002) 165-175
29. Zhang Y., Shoda L., Brayton K., Estes D.M., Palmer G.H., and Brown W.C. Induction of interleukin-6 and interleukin-12 in bovine B lymphocytes, monocytes, and macrophages by a CpG oligodeoxynucleotide (ODN 2059) containing the GTCGTT motif. J Interfer Cytokine Res 21 (2001) 871-881
30. Ray N., and Krieg A.M. Oral pretreatment of mice with CpG DNA reduces susceptibility to oral or intraperitoneal challenge with virulent Listeria moncytogenes. Infect Immun 71 (2003) 4398-4404
31. Hemmi H., Takeuchi O., Kawai T., Kaisho T., Sato S., Sanjo H., et al. A Toll-like receptor recognizes bacterial DNA. Nature 408 (2000) 740-745
32. Krieg A.M. Mechanisms and applications of immune stimulatory CpG oligodeoxynucleotides. Biochim Biophys Acta 1489 (1999) 107-116
33. Hartmann G., Battiany J., Poeck H., Wagner M., Kerkmann M., Lubenow N., et al. Rational design of new CpG oligonucleotides that combine B cell activation with high IFN-α; induction in plasmacytoid dendritic cells. Eur J Immunol 33 (2003) 1633-1641
34. Marshall J.D., Fearon K., Abbate C., Subramanian S., Yee P., Gregorio J., et al. Identification of a novel CpG DNA class and motif that optimally stimulate B cell and plasmacytoid dendritic cell functions. J Leukoc Biol 73 (2003) 781-792
35. Jurk M., Schulte B., Kritzler A., Noll B., Uhlmann E., and Wader T. C-Class CpG ODN: sequence requirements and characterization of immunostimulatory activities on mRNA level. Immunobiology 209 (2004) 141-154
36. Livak K.J., and Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2- delta delta method. Methods 25 (2001) 402-408
37. Ainsworth D.M., Eicker S.W., Yeagar A.E., Sweeney C.R., Viel L., Tesarowski D., et al. Associations between physical examination, laboratory, and radiographic findings and outcome and subsequent racing performance of foals with Rhodococcus equi infection: 115 cases (1984-1992). J Am Vet Med Assoc 213 (1998) 510-515
38. Boyd N.K., Cohen N.D., Lim W.S., Martens R.J., Chaffin M.K., and Ball J.M. Temporal changes in cytokine expression of foals during the first month of life. Vet Immunol Immunopathol 92 (2003) 75-85
39. Prescott J.F., and Yager J.A. The control of Rhodococcus equi pneumonia in foals. In: Plowright W., Rossdale PD., and Wade JF. (Eds). Equine infectious diseases VI. Newmarket (1992), R&W Publications, UK 21-25
40. Breathnach C.C., Sturgill-Wright T., Stiltner J.L., Adams A.A., Lunn D.P., and Horohov D.W. Foals are interferon gamma-deficient at birth. Vet Immunol Immunopathol 112 (2006) 199-209
41. Chaffin M.K., Cohen N.D., Martens R.J., Edwards R.F., and Nevill M. Foal-related risk factors associated with development of Rhodococcus equi pneumonia on farms with endemic infection. J Am Vet Med Assoc 223 (2003) 1791-1799
42. Martens R.J., Cohen N.D., Chaffin M.K., Takai S., Doherty C.L., Angulo A.B., et al. Evaluation of 5 serologic assays to detect Rhodococcus equi pneumonia in foals. J Am Vet Med Assoc 221 (2002) 825-833
43. Gold J.R., Perkins G.A., Erb H.N., and Ainsworth D.M. Cytokine profiles of peripheral blood mononuclear cells isolated from septic and healthy neonatal foals. J Vet Intern Med 21 (2007) 482-488
44. Langrish C.L., Buddle J.C., Thrasher A.J., and Goldblatt D. Neonatal dendritic cells are intrinsically biased against Th-1 immune responses. Clin Exp Immunol 128 (2002) 118-123
45. Flynn J., Chan J., Triebold K., Dalton D.K., Stewart T.A., and Bloom B.R. An essential role for interferon in resistance to Mycobacterium tuberculosis infection. J Exp Med 178 (1993) 2249-2254
46. Kanaly S.T., Hines S.A., and Palmer G.H. Cytokine modulation alters pulmonary clearance of Rhodococcus equi and development of granulomatous pneumonia. Infect Immun 63 (1995) 3037-3041
47. Kohler A.K., Stone D.M., Hines M.T., Byrne B.A., Alperin D.C., Norton L.K., et al. Rhodococcus equi secreted antigens are immunogenic and stimulate a type 1 recall response in the lungs of horses immune to R. equi infection. Infect Immun 71 (2003) 6329-6337
48. McMurray D.N. Determinants of vaccine-induced resistance in animal models of pulmonary tuberculosis. Scand J Infect Dis 33 (2001) 175-178
49. Jacks S., Giguere S., Crawford P.C., and Castleman W.L. Experimental infection of neonatal foals with Rhodococcus equi triggers adult-like gamma interferon induction. Clin Vaccine Immunol 14 (2007) 669-677
50. Diehl S R.M. The two faces of IL-6 on Th1/Th2 differentiation. Mol Immunol 39 (2002) 531-536
51. Dalrymple S.A., Lucian L.A., Slattery R., McNeil T., Aud D.M., Fuchino S., et al. Interleukin-6-deficient mice are highly susceptible to Listeria monocytogenes infection: correlation with inefficient neutrophilia. Infect Immun 63 (1995) 2262-2268
52. Ladel C.H., Blum C., Dreher A., Reifenberg K., Kopf M., and Kaufmann S.H. Lethal tuberculosis in interleukin-6-deficient mutant mice. Infect Immun 65 (1997) 4843-4849
53. Florido M., Goncalves A.S., Silva R.A., Ehlers S., Cooper A.M., and Appelberg R. Resistance of virulent Mycobacterium avium to gamma interferon-mediated antimicrobial activity suggests additional signals for induction of mycobacteriostasis. Infect Immun 67 (1999) 3610-3618
54. Goriely S., and Goldman M. The interleukin-12 family: new players in transplantation immunity?. Am J Transplant 7 (2007) 278-284
55. Rudner X.L., Happel K.I., Young E.A., and Shellito J.E. Interleukin-23 (IL-23)-IL-17 cytokine axis in murine Pneumocystis carinii infection. Infect Immun 75 (2007) 3055-3061
56. Watford W.T., Moriguchi M., Morinobu A., and O'Shea J.J. The biology of IL-12: coordinating innate and adaptive immune responses. Cytokine Growth Fact Rev 14 (2003) 361-368
57. Booth J.S., Nichani A.K., Benjamin P., Dar A., Krieg A.M., Babiuk L.A., et al. Innate immune responses induced by classes of CpG oligodeoxynucleotides in ovine lymph node and blood mononuclear cells. Vet Immunol Immunopathol 115 (2007) 24-34
58. Harandi A.M., Eriksson K., and Holmgren J. A protective role of locally administered immunostimulatory CpG oligodeoxynucleotide in a mouse model of genital herpes infection. J Virol 77 (2003) 953-962
59. Wernette C.M., Smith B.F., Barksdale Z.L., Hecker R., and Baker H.J. CpG oligodeoxynucleotides stimulate canine and feline immune cell proliferation. Vet Immunol Immunopathol 84 (2002) 223-236
60. Gramzinski R.A., Doolan D.L., Sedegah M., Davis H.L., Krieg A.M., and Hoffman S.L. Interleukin-12- and gamma interferon-dependent protection against malaria conferred by CpG oligodeoxynucleotide in mice. Infect Immun 69 (2001) 1643-1649
61. Jansky L.R.P., and Kopecky J. Dynamics of cytokine production in human peripheral blood mononuclear cells stimulated by LPS or infected by Borrelia. Physiol Res 52 (2003) 593-598
62. Pontarollo R.A., Rankin R., Babiuk L.A., Godson D.L., Griebel P.J., Hecker R., et al. Monocytes are required for optimum in vitro stimulation of bovine peripheral blood mononuclear cells by non-methylated CpG motifs. Vet Immunol Immunopathol 84 (2002) 43-59